Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Bayer

< Previous 1 2 3 4 5 6 7 8 Next >
Bayer and Recursion focus research collaboration on Oncology
From Bayer
Via Business Wire
Alka-Seltzer® Teams Up with George Kittle to Encourage Football Fans to ‘Say Yes’ to Going Big on Game Days
From Bayer
Via Business Wire
New Interim, Real-World Data Provides Additional Insights on Hyperkalemia and Safety of Kerendia® (finerenone) for Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
From Bayer
Via Business Wire
New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
From Bayer
Via Business Wire
Bayer and Broad Institute of MIT and Harvard Extend Research Collaboration to Develop New Cancer Therapies
From Bayer
Via Business Wire
FieldView and Combyne Platform Integration Helps Farmers Better Manage Grain Marketing and Build Profitability Insights
From Bayer
Via Business Wire
Bayer Unveils Latest Data from Oncology Portfolio at ESMO Congress 2023
From Bayer
Via Business Wire
Bayer and Dollar General Partner to Increase Access to Fruit and Veggies, Celebrate National School Lunch Week
From Bayer
Via Business Wire
Bayer to Partner With Twist Bioscience to Accelerate Drug Discovery
From Bayer
Via Business Wire
The Menopause Society Annual Meeting 2023: Bayer to present latest real-world evidence of menopausal symptoms and their treatment
From Bayer
Via Business Wire
Bayer’s Kerendia® (finerenone) Included in Latest Focused Guideline Clinical Updates from European Society of Cardiology
From Bayer
Via Business Wire
Bayer Expands Clinical Development Program Investigating Finerenone for Potential Treatment of Heart Failure
From Bayer
Via Business Wire
Bayer and Kroger Team to Help Improve Access to Health and Nutrition in Rural America
From Bayer
Via Business Wire
FieldView Rolls Out New Capabilities For Post-Harvest Analysis and Reporting
From Bayer
Via Business Wire
One in Four American Adults Would Rather Not Know They Have Cancer
From Bayer
Via Business Wire
Bayer Donates $500K to Support Maui Community After Devastating Fires
From Bayer
Via Business Wire
The Terror is Hatching: Bayer Unveils Upcoming “Rootworm Week”
From Bayer
Via Business Wire
Bayer Earns Top Score on 2023 Disability Equality Index
From Bayer
Via Business Wire
Bayer and Luke Bryan Reunite for Annual #HerestotheFarmer Campaign in Support of Feeding America and Rural Communities
From Bayer
Via Business Wire
Bayer initiates Phase III studies with investigational contrast agent gadoquatrane
From Bayer
Via Business Wire
FDA approves Bayer’s Ultravist® (iopromide) injection for contrast-enhanced mammography
From Bayer
Via Business Wire
Bayer to Investigate Finerenone in Phase III Study in Adults With Chronic Kidney Disease Associated With Type 1 Diabetes
From Bayer
Via Business Wire
Bayer Announces Senior Bayer Representative and President of Bayer U.S.
From Bayer
Via Business Wire
Bayer Announces Changes to U.S. Country Leadership Team
From Bayer
Via Business Wire
Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics
From Bayer
Via Business Wire
Latest Vitrakvi® (larotrectinib) Subgroup Analyses at ASCO 2023 Showcase Long-Term Efficacy and Safety Profile in Adult and Pediatric Patients with NTRK Gene Fusion Cancer, Across Solid Tumors
From Bayer
Via Business Wire
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
From Bayer
Via Business Wire
Bayer Launches Unit to Develop New Precision Health Consumer Products
From Bayer
Via Business Wire
Bayer Presents New Data Across Oncology Portfolio at the 2023 ASCO Annual Meeting
From Bayer
Via Business Wire
Bayer launches Seeing Red campaign around the treatment of Heavy Menstrual Bleeding (HMB)
From Bayer
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.